SCHEMBL277614

SCHEMBL277614

CCCCCC(CCC)CNCC(CCC)CCCCC

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.62
TSHR P16473 3/20 0.62
CYP3A4 P08684 1/20 0.62
LMNA P02545 1/20 0.46
KDM4E B2RXH2 1/20 0.40
ADH1B P00325 1/20 0.39
ADH1C P00326 1/20 0.39
ADH1A P07327 1/20 0.39
ADH4 P08319 1/20 0.39
ADH7 P40394 1/20 0.39
OPRM1 P35372 1/20 0.39
TDP1 Q9NUW8 1/20 0.36
LCK P06239 1/20 0.35
PPARD Q03181 1/20 0.35
ZDHHC20 Q5W0Z9 1/20 0.35
ZDHHC2 Q9UIJ5 1/20 0.35
DNM1 Q05193 2/20 0.35
THRB P10828 1/20 0.33
TRPA1 O75762 1/20 0.33
DDAH1 O94760 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15057305 0.98 ALDH1A1 (0.60) ALDH1A1TSHRCYP3A4LMNAKDM4E
SCHEMBL16236848 0.98 ALDH1A1 (0.60) ALDH1A1TSHRCYP3A4LMNAKDM4E
SCHEMBL16236793 0.95 ALDH1A1 (0.64) ALDH1A1TSHRCYP3A4LMNAKDM4E
SCHEMBL965056 0.92 TSHR (0.65) ALDH1A1TSHRCYP3A4LMNAKDM4E
SCHEMBL965573 0.92 TSHR (0.65) ALDH1A1TSHRCYP3A4LMNAKDM4E
SCHEMBL16236555 0.92 ALDH1A1 (0.73) ALDH1A1TSHRCYP3A4LMNAKDM4E
SCHEMBL965893 0.92 TSHR (0.65) ALDH1A1TSHRCYP3A4LMNAKDM4E
SCHEMBL16237314 0.92 ALDH1A1 (0.73) ALDH1A1TSHRCYP3A4LMNAKDM4E
SCHEMBL24735755 0.91 TSHR (0.79) ALDH1A1TSHRCYP3A4LMNAKDM4E
Magnesium Chloride Anhydrous SCHEMBL28044649 0.91 ALDH1A1 (0.54) ALDH1A1TSHRCYP3A4LMNAKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 127 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20160096819-A1 PROCESS FOR PREPARING N-SUBSTITUTED 1H-PYRAZOLE-5-CARBOXYLIC ACID COMPOUNDS AND DERIVATIVES THEREOF BASF SE (DE) 2016-04-07 US claimed
EP-2997020-A1 PROCESS FOR PREPARING N-SUBSTITUTED 1H-PYRAZOLE-5-CARBOXYLIC ACID COMPOUNDS AND DERIVATIVES THEREOF BASF SE (DE) 2016-03-23 EP claimed
CN-105189477-A Process for preparing n-substituted 1h-pyrazole-5-carboxylic acid compounds and derivatives thereof BASF SE 2015-12-23 CN claimed
WO-2014184343-A1 PROCESS FOR PREPARING N-SUBSTITUTED 1H-PYRAZOLE-5-CARBOXYLIC ACID COMPOUNDS AND DERIVATIVES THEREOF BASF SE (DE) 2014-11-20 WO claimed
EP-4532642-B1 NEW LOW VISCOSITY FUNCTIONAL FLUIDS BASF SE (DE) 2026-04-22 EP disclosed
EP-4532642-A1 NEW LOW-VISCOSITY FUNCTIONAL LIQUIDS BASF SE (DE) 2025-04-09 EP disclosed
CN-115003775-B Colorant for heat transfer fluid and composition containing same KD精细化工有限公司 2024-03-19 CN disclosed
CN-114787288-B Colorant for heat transfer fluid and composition containing same KD精细化工有限公司 2024-02-13 CN disclosed
WO-2023232577-A1 NEW LOW-VISCOSITY FUNCTIONAL LIQUIDS BASF SE (DE) 2023-12-07 WO disclosed
EP-4286497-A1 NEW LOW VISCOSITY FUNCTIONAL FLUIDS BASF SE (DE) 2023-12-06 EP disclosed
US-20230053517-A1 COLORANT FOR HEAT TRANSFER FLUID, AND COMPOSITION COMPRISING SAME KD FINECHEM CO., LTD. (KR) 2023-02-23 US disclosed
US-20220363697-A1 COLORANT FOR HEAT TRANSFER FLUID, AND COMPOSITION COMPRISING SAME KD FINECHEM CO., LTD. (KR) 2022-11-17 US disclosed
US-20080027068-A1 HETEROCYCLIC COMPOUNDS AND THROMBOPOIETIN RECEPTOR ACTIVATORS NISSAN CHEMICAL INDUSTRIES LIMITED (JP) 2008-01-31 US disclosed
EP-1845090-A1 AMIDE COMPOUND AND THROMBOPOIETIN RECEPTOR ACTIVATOR Nissan Chemical Industries, Ltd. (JP) 2007-10-17 EP disclosed
EP-1819692-A1 3-ETHYLIDENEHYDRAZINO SUBSTITUTED HETEROCYCLIC COMPOUNDS AS THROMBOPOIETIN RECEPTOR ACTIVATORS Nissan Chemical Industries, Ltd. (JP) 2007-08-22 EP disclosed
CN-1798739-A 3-alkylidenehydrazino substituted heteroaryl compounds as thrombopoietin receptor activators NISSAN CHEMICAL IND LTD (JP) 2006-07-05 CN disclosed
WO-2006062240-A1 3-ETHYLIDENEHYDRAZINO SUBSTITUTED HETEROCYCLIC COMPOUNDS AS THROMBOPOIETIN RECEPTOR ACTIVATORS NISSAN CHEMICAL INDUSTRIES, LTD. (JP) 2006-06-15 WO disclosed
US-20060094694-A1 Heterocyclic compounds and thrombopoietin receptor activators NISSAN CHEMICAL INDUSTRIES LIMITED (JP) 2006-05-04 US disclosed
EP-1636192-A1 3-ALKYLIDENEHYDRAZINO SUBSTITUTED HETEROARYL COMPOUNDS AS THROMBOPOIETIN RECEPTOR ACTIVATORS Nissan Chemical Industries, Ltd. (JP) 2006-03-22 EP disclosed
WO-2004108683-A1 3-ALKYLIDENEHYDRAZINO SUBSTITUTED HETEROARYL COMPOUNDS AS THROMBOPOIETIN RECEPTOR ACTIVATORS NISSAN CHEMICAL INDUSTRIES, LTD. (JP) 2004-12-16 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060094694-A1 Heterocyclic compounds and thrombopoietin receptor activators NR2C2, ROR1, NR0B2 ALDH1A1 3160/4885TSHR 47/4885CYP3A4 337/4885
US-20080027068-A1 HETEROCYCLIC COMPOUNDS AND THROMBOPOIETIN RECEPTOR ACTIVATORS NR2C2, ROR1, NR0B2 ALDH1A1 3206/4885TSHR 44/4885CYP3A4 353/4885
US-20220363697-A1 COLORANT FOR HEAT TRANSFER FLUID, AND COMPOSITION COMPRISING SAME TRMT1, GFPT1, TRMT1L ALDH1A1 574/4885TSHR 4672/4885CYP3A4 1082/4885
US-20160096819-A1 PROCESS FOR PREPARING N-SUBSTITUTED 1H-PYRAZOLE-5-CARBOXYLIC ACID COMPOUNDS AND DERIVATIVES THEREOF CA3, CA2, CA1 ALDH1A1 989/4885TSHR 959/4885CYP3A4 250/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.